Wei-Peng Teo1, Aravinda Kannan2, Pei-Kee Loh3, Effie Chew4, Vijay Kumar Sharma5, Yee-Cheun Chan5. 1. Lecturer, School of Medical and Applied Sciences , Central Queensland University, Australia . 2. Medical Technologist, Neurodiagnostic Laboratory, National University Hospital , Singapore . 3. Consultant Neurologist, Ara Damansara Medical Centre , Malaysia . 4. Senior Consultant, Rehabilitative Medicine, Assistant Professor, National University Hospital;Yong Loo Lin School of Medicine, National University of Singapore , Singapore . 5. Senior Consultant, Division of Neurology, Assistant Professor, National University Hospital;Yong Loo Lin School of Medicine, National University of Singapore , Singapore .
Abstract
BACKGROUND: Two small studies had evaluated the efficacy of rTMS in migraine. One tested high frequency rTMS over the dorsolateral prefrontal cortex while the other evaluated 1 Hz rTMS over the vertex. AIM: To test the feasibility of 10 Hz rTMS of motor cortex as an adjunctive therapy in patients with chronic migraine Materials and Methods: We randomized (2:1 ratio) chronic migraine patients on medical preventive treatment to receive either rTMS or sham therapy for 10 sessions. rTMS (80% resting motor threshold, 10Hz, 20 trains, 5 secs/train, inter-train interval 1 min, total 1000 stimuli/session) was applied over the right motor cortex. RESULT: Nine patients were randomized. Six received rTMS and three had sham therapy. Three patients in the rTMS arm withdrew from the study due to increased headache frequency and discomfort from the treatment. The remaining six cases (3 rTMS, 3 sham) completed the study. The study was prematurely stopped due to the significant worsening of headache from rTMS. No significant differences in outcome measures were found between real and sham rTMS. CONCLUSION: Although the study was terminated prematurely, the high dropout rate (50%) due to worsening headaches suggested that rTMS over the motor cortex is poorly tolerated in chronic migraine.
RCT Entities:
BACKGROUND: Two small studies had evaluated the efficacy of rTMS in migraine. One tested high frequency rTMS over the dorsolateral prefrontal cortex while the other evaluated 1 Hz rTMS over the vertex. AIM: To test the feasibility of 10 Hz rTMS of motor cortex as an adjunctive therapy in patients with chronic migraine Materials and Methods: We randomized (2:1 ratio) chronic migrainepatients on medical preventive treatment to receive either rTMS or sham therapy for 10 sessions. rTMS (80% resting motor threshold, 10Hz, 20 trains, 5 secs/train, inter-train interval 1 min, total 1000 stimuli/session) was applied over the right motor cortex. RESULT: Nine patients were randomized. Six received rTMS and three had sham therapy. Three patients in the rTMS arm withdrew from the study due to increased headache frequency and discomfort from the treatment. The remaining six cases (3 rTMS, 3 sham) completed the study. The study was prematurely stopped due to the significant worsening of headache from rTMS. No significant differences in outcome measures were found between real and sham rTMS. CONCLUSION: Although the study was terminated prematurely, the high dropout rate (50%) due to worsening headaches suggested that rTMS over the motor cortex is poorly tolerated in chronic migraine.
Authors: L García-Larrea; R Peyron; P Mertens; M C Gregoire; F Lavenne; D Le Bars; P Convers; F Mauguière; M Sindou; B Laurent Journal: Pain Date: 1999-11 Impact factor: 6.961
Authors: M Teepker; J Hötzel; N Timmesfeld; J Reis; V Mylius; A Haag; W H Oertel; F Rosenow; K Schepelmann Journal: Cephalalgia Date: 2010-02 Impact factor: 6.292
Authors: C Lovati; D D'Amico; S Rosa; M Suardelli; E Mailland; P Bertora; S Pomati; C Mariani; G Bussone Journal: Neurol Sci Date: 2007-05 Impact factor: 3.307
Authors: Hatem S Shehata; Eman H Esmail; Ahmad Abdelalim; Shaimaa El-Jaafary; Alaa Elmazny; Asmaa Sabbah; Nevin M Shalaby Journal: J Pain Res Date: 2016-10-07 Impact factor: 3.133
Authors: Charlotte Nettekoven; Julia Pieczewski; Volker Neuschmelting; Kristina Jonas; Roland Goldbrunner; Christian Grefkes; Carolin Weiss Lucas Journal: Hum Brain Mapp Date: 2021-08-13 Impact factor: 5.038